ALLEGAN, MI (WHTC) - Perrigo posted record numbers in its quarterly report issued before the markets opened this morning. The Allegan-based generic drug maker earned $1.52 per share for the first three months of fiscal 2014 on net sales of 933 million dollars, up around 20 percent, and with gross and operating margins of 190 and 120 basis points, respectively. Shareholders meet on November 18th to consider Perrigo’s purchase of Elan Corporation.
Peter Schiff Show 6:00 PM - 7:00 PM
On Air Now.